Shilpa Medicare share news, announcements and annual reports
NSE: SHILPAMEDBSE: 530549Pharmaceuticals & BiotechnologySmall Cap
Shilpa Medicare Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 1995 on BSE, Dec 2009 on NSE
Last close ₹935.60up ₹3.60 (0.39%)BSE ₹935.10
Share price at the NSE close on 29 Oct 2026. Previous close ₹932.00.
29 Oct: open ₹932.00, high ₹949.80, low ₹922.90
52-week range of traded prices to 29 Oct 2026
₹259.50Low, 27 Jan 2026₹1,095.00High, 1 Oct 2026
- Under NSE's long-term additional surveillance, stage I, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹18,299 Cr637th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 61.55
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹30 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 68.58
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 7.06
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.06%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 12.0%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹30 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 10.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 10.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.25
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,86,41043.9% delivered
Shilpa Medicare board and management
32 filed, newest first.
Aug 2026
Jul 2026
Apr 2026
Sep 2022
Aug 2022
Jul 2022
May 2022
Mar 2022
Feb 2022
Sep 2021
Jan 2021
Oct 2020
Oct 2019
Sep 2019
21 Sep · Management
May 2019
Apr 2019
15 Apr · Management
May 2018
28 May · Management
Nov 2017
Oct 2017
Dec 2016
Aug 2016
Jan 2016
Mar 2015
Feb 2012
14 Feb · Management
Resignation of Mr. Abhay Bhindumadhav Upasani from the directorship of the Company due to preoccupation and the Board of the Company has considered and taken on record the same w.e.f. February 09, 2012.
Feb 2011
2 Feb · Management
Mr. Ajeet Singh Karan a Nominee of Baring India Private Equity Fund III Limited has been co-opted as an Additional Director of the Company w.e.f January 28, 2011.
Mar 2010
29 Mar · Management
Mr. Pramod Kasat, a Financial Professional working with one of the reputed international investment group, has been co-opted as an Additional Director on the Board to act as Independent Director with effect from March 16, 2010.8 Mar · Management
Mr.Atim Kabra a Director of the Company has resigned w.e.f February 26, 2010.